Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma

The antibody-drug conjugate (ADC) cAC10-vcMMAE consists of the tubulin inhibitor monomethyl auristatin E (MMAE) conjugated to the chimeric anti-CD30 monoclonal antibody cAC10. This ADC potently interferes with the growth of CD30-positive haematological tumours, including Hodgkin lymphoma (HL) and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Oflazoglu, Ezogelin, Kissler, Kim M, Sievers, Eric L, Grewal, Iqbal S, Gerber, Hans-Peter
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440525/
https://www.ncbi.nlm.nih.gov/pubmed/18477046
http://dx.doi.org/10.1111/j.1365-2141.2008.07146.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440525/
https://www.ncbi.nlm.nih.gov/pubmed/18477046
http://dx.doi.org/10.1111/j.1365-2141.2008.07146.x

Ejemplares similares